Morphosys AG Receivables

Morphosys AG (MOR) currently reports a receivables of $31M as of March 2024. That compares with $78M in the prior-year period — down 60.5% year over year. Use the charts on this page to explore Morphosys AG's receivables history and peer comparisons.

Morphosys AG's receivables decreased from $78M to $31M — a 60.5% year-over-year decrease (period ending March 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Morphosys AG reported $31M in receivables as of March 2024. That compares with $78M in the prior-year period — down 60.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $31M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Morphosys AG, and consider following MOR for alerts when major investors trade the stock.

Morphosys AG is classified in the Healthcare sector. On receivables, it currently shows $31M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing MOR with unrelated industries.